Revenue Performance - Total revenues for Q3 FY2025 were $3.80 million, a decrease of 14.7% from $4.46 million in Q3 FY2024[6] - Revenues from third-party cross-border freight solutions decreased to $2.86 million, down 25.4% from $3.82 million year-over-year[6] - For the nine months ended March 31, 2025, total revenues were $11.48 million, a decrease of 15.1% from $13.53 million in the same period of FY2024[10] - Total revenue for the nine months ended March 31, 2025, was $11,480,283, a decrease of 15.2% from $13,525,342 in the same period of 2024[30] - Revenues from Asia-based customers for the nine months increased to $9.1 million, up from $8.1 million in the prior year[17] Operating Expenses - Operating expenses for Q3 FY2025 increased to $1.79 million, up from $0.94 million in Q3 FY2024[8] - Operating expenses for the nine months ended March 31, 2025, were $5,595,537, significantly higher than $2,898,660 in the same period of 2024[30] Net Loss and Profitability - The net loss attributable to the Company for Q3 FY2025 was $1.07 million, compared to a net income of $0.01 million in Q3 FY2024[9] - The loss from operations for the nine months ended March 31, 2025, was $4.40 million, compared to a loss of $0.21 million for the same period in FY2024[13] - Net loss attributable to the Company for the nine months ended March 31, 2025, was $4,353,023, compared to a net loss of $227,268 in the same period of 2024[30] - The company reported a comprehensive loss of $4,361,626 for the nine months ended March 31, 2025, compared to a comprehensive loss of $227,171 in the same period of 2024[30] Cash Flow and Assets - Cash at the end of the period increased to $1,499,257 as of March 31, 2025, from $123,550 at the beginning of the period[33] - Cash flows from operating activities resulted in a net cash used of $2,171,304 for the nine months ended March 31, 2025, compared to a net cash provided of $161,644 in the same period of 2024[32] - Total current assets increased to $5,012,413 as of March 31, 2025, from $3,539,772 as of June 30, 2024[28] Liabilities - Total liabilities rose to $9,189,975 as of March 31, 2025, compared to $8,553,967 as of June 30, 2024[28] Acquisition and Growth Strategy - The acquisition of Hupan Pharmaceutical contributed $715,362 to revenues for the nine months ended March 31, 2025[5] - The Company is focused on expanding its footprint in China's pharmaceutical distribution market and integrating Hupan Pharmaceutical into its operations[4] Share Information - The weighted average shares outstanding for basic and diluted earnings per share increased to 7,500,000 as of March 31, 2025, from 6,000,000 in the same period of 2024[30] IPO and Funding - The Company raised approximately $6.75 million from its IPO on July 1, 2024, to support growth strategies[5]
Lakeside Holding Limited(LSH) - 2025 Q3 - Quarterly Results